Group Health Cooperative Logo Group Health Center for Health Studies

 skip navigation

site map  search  ghc.org    
         
CHS Research News
Volume 17, Issue 2
Spring 2005
 
 

CHS Research News
Vol 17, Issue 2, Spring 2005

Center News

by Joan DeClaire

 

New Findings

"e-BP" explores Web-based help for patients with hypertension

Can Web-based information and communication technology enhance care for people with hypertension? Scientists from Group Health’s Center for Health Studies (CHS) are exploring this question in a four-year, $2.8 million study called "e-BP." The NIH-funded project is slated to start enrolling Group Health members with high blood pressure into the study this summer.

Group Health provides a prime environment for this kind of study, says Beverly Green, MD, MPH, a CHS affiliate investigator co-leading the study. "One, Group Health is a leader in improving the care of patients with chronic health conditions. And two, Group Health has built an electronic medical record and patient Web portal that is centered on our patients’ needs first." Group Health’s Web portal, MyGroupHealth, is one of the largest of its kind—with more than 85,000 registered users to date—and is internationally recognized as a leading-edge example of patient-centered information technology.

A total of 780 study participants with uncomplicated hypertension will be randomly assigned to one of three groups. One group will receive usual care. The second will get home blood-pressure monitors and instructions for using MyGroupHealth (www.ghc.org). The third will get all of the above, plus support from a Group Health pharmacist via the secure e-mail feature on MyGroupHealth. Patients in this third group will e-mail their blood pressure readings to a study pharmacist, who, if necessary, will provide support for better medication use and lifestyle goals. The study team will then compare how the various interventions affect outcomes such as blood pressure control, change in diastolic and systolic blood pressure, cost of care, patient satisfaction, and patient health status.

"Early research indicates that electronic communications and access to online records may be especially valuable in caring for people who live with ongoing health conditions," explains James Ralston, MD, MPH, a CHS investigator who is also working on the project. "People with conditions like high blood pressure make decisions everyday that affect their health, and our system gives patients and their providers joint access to medical records and secure e-mail around the clock."

Adds Green, "With this study, we’ll find out what happens when we leverage that technology in a way that can support the use of self-monitoring and pharmacist assistance to improve blood pressure control and decrease the risk of heart disease and strokes."

Group Health Center for Health Studies will send letters to about 4,000 Group Health patients who potentially qualify for the study. Participants must be 25 to 75 years old, have high blood pressure, take medication for their condition, and have regular access to the Internet and an e-mail address.

The e-BP study is funded by the National Heart, Lung, and Blood Institute, which is part of the National Institutes of Health. Robert S. "Tom" Thompson, MD, and Beverly Green, MD—two physicians with Group Health’s Department of Preventive Care who also do research through CHS—are the co-principal investigators for the research team. Other team members are Assistant Director of Pharmacy Administration James Carlson, and Harold Goldberg, MD, from the University of Washington Department of Medicine, and CHS scientists James Ralston, MD, MPH, Sheryl Catz, PhD, Paul Fishman, PhD, and Carolyn Rutter, PhD. Lynda Tyll is the CHS manager coordinating the project.

The Group Health pharmacists who will be working with patients in the intervention arm of the study are Jilene Winther, Shannon Lavy, and Danette Feuling. Pharmacists Mary Fors and Lindsay Jahng assisted with the pilot phase of the study.

Top

 

Katherine Newton named associate director-external research

Katherine Newton, PhD, has been appointed to the position of associate director—external research at Group Health Center for Health Studies. A nationally respected researcher in the areas of women’s health and chronic illness, Newton first joined the Center as a postdoctoral fellow in 1995, and became an investigator in 1997. She held the post of acting associate director—internal research from 2000 to 2002, and has served as chair of the Center’s Scientific Policy Committee since 2002.

As associate director, Newton will help develop and guide a variety of external research projects. She will also be responsible for enhancing the Center’s alignment with Group Health, increasing integration of affiliate investigators, strengthening partnerships with other institutions, and managing clinician involvement in the Center’s research.

Newton holds a doctorate degree in epidemiology and a master’s degree in nursing from the University of Washington, and a bachelor’s degree in nursing from the University of California, San Francisco.

Top

 

A common bacterium leads to serious blood infections in many seniors, new Group Health study finds

A new study finds that E. coli bacteremia—a potentially life-threatening bloodstream infection caused by a common bacterium also associated with less dangerous urinary tract infections—poses a significant public health threat in the United States, especially among seniors.

The study, published by Group Health researchers in the May 2005 issue of the Journal of Infectious Diseases, finds that E.coli bacteremia may affect as many as 53,000 non-institutionalized people, aged 65 and older, each year. It also suggests that a vaccine or other preventive intervention, targeted at high-risk groups, could have an important, positive impact on public health.

The bacterium Escherichia coli (E. coli), which grows naturally in the human digestive tract, is a leading cause of urinary tract infections. Medical researchers have long known that E. coli is also a cause of bloodstream infection. But until this study, the number of non-institutionalized seniors affected by E. coli bacteremia has not been clear.

"E. coli is a less serious problem in the urinary tract, but if it spreads to the bloodstream it causes bacteremia, which can lead to a dangerous drop in blood pressure called septic shock," explained Lisa Jackson, MD, MPH, a senior investigator at Group Health’s Center for Health Studies and the lead author of the study. "Bacteremia is associated with a death rate of about 10 percent," Jackson added.

While there is a vaccine to protect seniors from pneumococcal bacteremia, which starts in the lungs, there is no similar vaccine to protect against E. coli bacteremia. "Our study finds E. coli bacteremia three times more common than the pneumococcal infection," said Jackson. "That suggests that development of a vaccine could save many lives."

While studies are underway at other institutions on a vaccine that would prevent bacteria from taking hold in the urinary tract, Jackson said she is not aware of any work currently underway to develop a vaccine specifically to prevent E. coli bacteremia.

Jackson’s study, conducted among 46,000 Group Health members, also identified risk factors for E. Coli bacteremia. In men, they include urinary catheterization and incontinence. In women, risk factors are linked to incontinence, congestive heart failure, and coronary artery disease.

Certain health behaviors can help prevent urinary tract infections, and, by association, may also help reduce the risk of bacteremia. Information on these preventive measures is available online at: http://kidney.niddk.nih.gov/kudiseases/pubs/uti_ez/index.htm#7.

Other study authors include Patti Benson of Group Health’s Center for Health Studies and Kathleen Neuzil, MD, Marcus Grandjean, and Jennifer L. Marino of the University of Washington.

Top

 

Study shows bone density testing is linked to fewer fractures

Offering bone density testing to women aged 60 and older as part of a comprehensive fracture prevention program can significantly reduce the total number of fractures in that population, according to a Group Health Cooperative study published in the March 2005 issue of the journal Medical Care.

Led by researchers from Group Health Center for Health Studies (CHS), the study evaluated the impact of three different fracture prevention strategies involving various levels of screening and education among more than 9,000 women, aged 60 to 80. The researchers found that offering bone density testing to all women in a program, regardless of their risk, resulted in a fracture rate that was 19 percent lower than offering testing only to high-risk women. The study also found that bone density testing was linked to a reduction in some fracture risk factors and a better understanding of osteoporosis.

"It's not the bone density test itself that makes the difference," said Andrea Z. LaCroix, PhD, senior investigator at CHS and the principal investigator on the study. "But the test appears to heighten women's awareness of bone health." It provides "a teachable moment for women" to get personalized feedback about their risk factors, education about osteoporosis, and consultation with their doctors, she added. "These are all important components of an effective fracture prevention program."

While past studies have shown a positive link between bone density testing and higher rates of drug therapy for osteoporosis treatment and prevention, this is the first large-scale study to show that bone density testing is linked to a reduction in fractures.

Finding effective strategies for reducing fractures is an important public health issue, the authors note. They point to an October 2004 report from the U.S. Surgeon General that set specific goals for Americans to improve bone health, in order to reduce fracture rates in the U.S. population by 2010. The authors noted that in 1999, nearly 300,000 hip fractures occurred among Americans aged 65 and older. Hip fractures are a significant cause of death and disability, and cost an estimated $8.7 million in health care annually in the United States.

"These findings will hopefully promote the implementation of effective fracture prevention programs in health care organizations that serve millions of older women in our country who are at risk of fracture," said LaCroix. The study results also support the recent U.S. Preventive Services Task Force recommendations that all women aged 65 and older be screened routinely for osteoporosis, the authors note.

To reduce fracture risk, women in the program were encouraged to:

  • Exercise regularly
  • Eat foods rich in calcium and Vitamin D
  • Avoid smoking
  • Maintain a healthy body weight
  • Consult with a doctor if in a high-risk group

More information about bone health is available at the Surgeon General's Web site.

The study was funded by a grant from Merck & Co., Inc. Other investigators on the study were Diana S.M. Buist, PhD, of CHS; and Susan K. Brenneman, PT, PhD, and Thomas A. Abbott III, PhD, of the Outcomes Research & Management Division at Merck & Co., Inc.

Top

 

JAMA commentary explores physician empathy as part of the healing process

Business scholars for more than 20 years have explored the concept of "emotional labor"—i.e., the management of emotions to present a certain image in service workers. Now, researchers from Group Health Cooperative and the University of Washington Business School have teamed up to explore how the concept can be applied to the medical profession.

"We propose that the emotional labor of physicians is characterized by the display of empathy," said Eric B. Larson, MD, MPH, director of Group Health Center for Health Studies and co-author of a commentary in the March 2, 2005 issue of the Journal of the American Medical Association.

"Empathy is essential to healing relationships, so it's something all health professionals should be expected to show—even when it's hard to do so."

Drawing from previous research that equates service workers' labor to the work of stage actors, Larson and his co-author, Xin Yao, a doctoral student in the UW Business School, describe a model for applying acting techniques to the delivery of empathy in doctor-patient interactions. They suggest that doctors can use two techniques separately or in combination—"deep acting," which uses imagination and emotional memories to generate genuine feelings of empathy for the patient, and "surface acting," in which the doctor forges emotional expressions inconsistent with internal feelings. This would allow the doctor to display behaviors the patient can interpret as empathic.

The authors contend that deep acting is preferred because it makes doctors more effective as healers. They also believe doctors have greater professional satisfaction and less professional burnout when they practice deep acting, but doctors may have to rely on surface acting when genuine empathy seems impossible. Surface acting may be needed, for example, in situations in which the doctor's values or beliefs are entirely different from the patient's.

The authors urge doctors to recognize that their work has an element of emotional labor and to consciously practice deep and surface acting to empathize with their patients. They also recommend long-term, regular training to help doctors develop empathy.

"This will be valuable for both physicians and patients facing the increasingly fragmented and technological world of modern medicine," the authors write.

"For patients, our message is that it's reasonable to expect physicians to show empathy," said Larson. "It's part of the physician's job."

Larson also urged health care consumers to seek long-term, continuous relationships with physicians they like. "The better the physician knows you, the easier it is to develop an empathic, healing relationship."

Top

 

 

Research Highlights

Increasing Pap screening adherence and improving the accuracy of Pap screening could reduce the incidence of invasive cervical cancer among women with access to screening, according to a new study by researchers from seven large health plans, including Group Health Cooperative. To reveal factors associated with screening failure, Wendy A. Leyden, MPH, of Kaiser Permanente Northern California, and colleagues examined the medical records of 833 women enrolled in the comprehensive health care plans who were diagnosed with cervical cancer despite having access to cancer screening and treatment services. They found that 56 percent of cases were in women who had not had a Pap test during the period 4–36 months prior to diagnosis, whereas 32 percent of cases were attributed to Pap test detection failure and 13 percent of cases to failure to follow up an abnormal test result. Most (81 percent) of the women with no Pap screening had had at least one unrelated outpatient visit 4–36 months prior to their cancer diagnosis. "Despite the many exciting new technologies that may improve our ability to predict or detect cervical neoplasia, we must not lose sight of the need to increase screening adherence," the authors wrote in the May 4, 2005 issue of the Journal of the National Cancer Institute. "Even the most perfect screening method will not detect disease in a woman who has not participated in the prevention process." Former CHS investigator Stephen Taplin, MD, MPH, (now with the National Cancer Institute) was the Group Health investigator on the study.

Breast density is related to tumor size, lymph node status, and lymphatic or vascular invasion in screen-detected cancers, according to a Group Health study published in the March 2005 issue of the journal Cancer Epidemiology Biomarkers & Prevention. CHS Research Associate Erin Aiello, PhD, is the lead author of the work, which was based on data from more than 500 Group Health enrollees. "Additional studies are needed to address whether these associations are due to density masking the detection of some tumors, a biological relationship, or both," concluded Aiello and her co-authors—CHS Assistant Investigator Diana Buist, PhD, and CHS affiliate investigators Emily White, PhD, of the UW Department of Epidemiology, and Peggy L. Porter, MD, of the Fred Hutchinson Cancer Research Center.

A one-year course of the antibiotic azithromycin taken weekly did not alter the risk of cardiac events among patients with stable coronary artery disease, according to a study in the April 21, 2005 issue of The New England Journal of Medicine. Co-authored by CHS Associate Investigator Lisa Jackson, MD, MPH, the study reported the results of a randomized, double-blind, placebo-controlled trial conducted at 28 centers in the United States. The lead author of the study was J. Thomas Grayston, MD, professor of epidemiology at the University of Washington. Many previous studies have found the bacteria Chlamydia pneumoniae in the arterial plaque of patients with coronary artery disease. This led to the investigation of whether antibiotics could be used to treat the bacteria and therefore reduce the risk of cardiac events.

Urinary incontinence is highly prevalent in women across their adult life span, and its severity increases linearly with age, according to a Group Health study published in the March 14, 2005 issue of the Archives of Internal Medicine. The lead author of the article is Jennifer Melville, MD, MPH, of the UW Department of Obstetrics and Gynecology and CHS affiliate investigator. Other authors include UW psychiatry professor Wayne Katon, MD, CHS Analyst/Programmer Kristin Delaney, MPH, and CHS Associate Investigator Katherine Newton, PhD. The study of 6,000 women found that older age, higher body mass index, greater medical co-morbidity, current major depression, history of hysterectomy, and having given birth increased the odds of urinary incontinence.

Current market forces discourage the development of a primary care-based health care system in the United States, according to an editorial by CHS Director Eric Larson, MD, MPH, in the April 19, 2005 Annals of Internal Medicine. Along with co-authors Kenneth B. Roberts, MD, of the University of North Carolina School of Medicine and Kevin Grumbach, MD, of the University of California, San Francisco, Larson suggests that solutions might be found by examining how society has tackled other tough public health problems—issues like reducing smoking rates and increasing automobile safety. In addition, they call for combining research with advocacy, public discussion, and policy to create successful campaigns for change.

Community-based mammography facilities do not have enough radiologists and certified technologists to adequately deliver screening and diagnostic services to the public, and the situation may get worse, according to a study published in the May 2005 issue of the journal Radiology. Led by Carl D’Orsi, MD, professor of radiology at Emory University, the study is based on a 2001–2002 survey of 45 mammography facilities (including six from Group Health) in Washington, New Hampshire, and Colorado. The article explores the clinical implications of the shortage and suggests ways to attract radiologists and technologists to the field of mammography. Co-authors of the study include CHS researchers Linn Abraham, MS, and Bill Barlow, PhD, Stephen Taplin, MD, MPH (now with the National Cancer Institute), and CHS Affiliate Investigator Joann G. Elmore, MD, MPH, of Harborview Medical Center.

Racial inequities exist in breast cancer detection, diagnosis, and initiation of treatment, according to a study published in the February 2005 issue of the journal Medical Care. Conducted in Connecticut by researchers from UW, Harvard Medical School, and CHS, the study found racial disparities "at each step in the evaluation and treatment clinical pathway, including method of detection, timing from first symptoms of cancer to pathologic diagnosis, and timing from diagnosis to initiation of treatment." The study was led by UW’s Joanne Elmore, MD, MPH, of Harborview Medical Center, who serves as an affiliate investigator at CHS. CHS Director Eric Larson, MD, MPH, was a co-author. "The findings highlight the need to provide equal opportunity for timing medical care and treatment," the authors wrote.

Implementation of the Chronic Care Model (developed by the MacColl Institute at CHS) has resulted in a 49.6 percent decrease in infant mortality among the three million people living in the resource-poor Russian state of Tver Oblast. This is according to a lecture published in the April 2005 issue of Health Services Research. Author Don Berwick, MD, MPP, president and CEO of the Institute for Healthcare Improvement, points to this result as an example of the power of well-conducted health services research. The Chronic Care Model "offers an evidence-based, disciplined, practical understanding of what care should look like," Berwick writes. "In action, it is brilliantly successful. Dozens of organizations are now using this model to make profound changes in the well-being, function, risk level and cost of care for thousands of patients."

Integrating depression care into primary medicine can improve the mental health of African American and Latino seniors, according to a study conducted at 18 sites across the United States, including Group Health. The study, which appears in the April 2005 issue of Medical Care, is part of Project IMPACT, a randomized clinical trial that compares usual care to having a depression-care manager work with primary-care providers to treat seniors with depression. When barriers to specialized treatment are reduced, older Latinos and African Americans are more likely to make use of mental health services—an innovation that addresses an historical disparity in their care, the researchers concluded. CHS Affiliate Investigator Elizabeth Lin, MD, MPH, led the Group Health arm of the study.

A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study conducted at Group Health and the UW. Published in the February 23, 2005 issue of the Journal of the American Medical Association, the study is important because management of these infections has been made more complicated in recent years by increasing antimicrobial resistances. CHS Associate Investigator Delia Scholes, PhD, is a co-author of the study, which was led by Thomas M.Hooton, MD, of the UW Department of Medicine.

Top

 

 

           
 
site map  search  ghc.org    
Copyright 2008 Group Health Cooperative. Revised: June 03, 2008. Contact Us